Washington Capital Management Inc. maintained its position in Henry Schein, Inc. (NASDAQ:HSIC) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 2,860 shares of the company’s stock at the end of the second quarter. Washington Capital Management Inc.’s holdings in Henry Schein were worth $523,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. SpiderRock Advisors LLC acquired a new position in Henry Schein during the first quarter worth approximately $102,000. Lee Financial Co acquired a new position in Henry Schein during the second quarter worth approximately $161,000. Westside Investment Management Inc. acquired a new position in Henry Schein during the first quarter worth approximately $168,000. JNBA Financial Advisors acquired a new position in Henry Schein during the first quarter worth approximately $170,000. Finally, Peddock Capital Advisors LLC increased its position in Henry Schein by 29.1% in the first quarter. Peddock Capital Advisors LLC now owns 1,097 shares of the company’s stock worth $186,000 after buying an additional 247 shares during the last quarter. Institutional investors and hedge funds own 90.84% of the company’s stock.
Shares of Henry Schein, Inc. (NASDAQ:HSIC) opened at 182.21 on Tuesday. The firm has a market capitalization of $14.45 billion, a PE ratio of 27.69 and a beta of 1.09. Henry Schein, Inc. has a 12 month low of $146.23 and a 12 month high of $186.99. The company has a 50 day moving average price of $183.52 and a 200-day moving average price of $174.31.
Henry Schein (NASDAQ:HSIC) last announced its quarterly earnings data on Tuesday, May 9th. The company reported $1.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.65 by $0.11. The firm had revenue of $2.92 billion during the quarter, compared to analyst estimates of $2.83 billion. Henry Schein had a return on equity of 19.74% and a net margin of 4.53%. Henry Schein’s quarterly revenue was up 7.7% on a year-over-year basis. During the same period in the previous year, the company earned $1.41 earnings per share. Equities research analysts expect that Henry Schein, Inc. will post $7.28 EPS for the current fiscal year.
TRADEMARK VIOLATION WARNING: This report was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://stocknewstimes.com/2017/08/01/henry-schein-inc-hsic-stake-maintained-by-washington-capital-management-inc.html.
A number of research analysts have recently commented on the company. Barrington Research increased their price objective on Henry Schein from $196.00 to $198.00 and gave the company an “outperform” rating in a report on Wednesday, May 10th. Zacks Investment Research upgraded Henry Schein from a “hold” rating to a “buy” rating and set a $204.00 price objective on the stock in a report on Thursday, May 25th. Credit Suisse Group reiterated a “hold” rating and issued a $160.00 price objective on shares of Henry Schein in a report on Thursday, July 13th. Craig Hallum assumed coverage on Henry Schein in a report on Tuesday, April 11th. They issued a “hold” rating on the stock. Finally, Stifel Nicolaus increased their price objective on Henry Schein from $174.00 to $178.00 and gave the company a “hold” rating in a report on Wednesday, May 10th. Eleven equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. Henry Schein presently has a consensus rating of “Hold” and a consensus price target of $183.40.
In related news, EVP Gerald A. Benjamin sold 12,578 shares of the business’s stock in a transaction dated Thursday, May 11th. The stock was sold at an average price of $175.10, for a total value of $2,202,407.80. Following the completion of the sale, the executive vice president now directly owns 44,061 shares of the company’s stock, valued at $7,715,081.10. The sale was disclosed in a filing with the SEC, which can be accessed through this link. 1.27% of the stock is owned by insiders.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
